| Value | ₹2.80 Cr |
|---|
NSE filing, NSE: VMART. Summary written from the filing by ALFA Finder's alert engine.
V-Mart Retail Ltd: key numbers
- Share price
- ₹762.50
- Market cap
- ₹6,068 Cr
- Revenue (annual)
- ₹3,789 Cr
- Net profit (annual)
- ₹124.0 Cr
- P/E (TTM)
- 44.1×Sector 61.5×
- Promoter holding
- 44.14%-0.01% QoQ
- FII holding
- 16.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from V-Mart Retail Ltd
All →V-Mart Retail Board Meeting Date
V-Mart Retail will hold a board meeting on 3 November 2026 to approve unaudited Q2 and half-year results. Trading window closed 1 October to 5 November 2026.
V-Mart Retail Management Change
Mr. Jayesh Kothari, President - Merchandising at V-Mart Retail Ltd, has resigned from his position due to health reasons. His resignation is effective from October 9, 2026.
V-Mart Retail Results Update
V-Mart Retail reported Q2 FY27 revenue of Rs. 953 Crores and opened 23 new stores, bringing the total store count to 613.
- new stores
- 23.0 stores
V-Mart Retail Price Movement Clarification
V-Mart Retail Limited clarified that the significant increase in its share trading volume is purely market-driven. The company confirms no undisclosed price-sensitive information exists.
V-Mart Retail Other Announcement
Crisil ESG Ratings & Analytics has independently assigned V-Mart Retail a 'Crisil ESG 62' rating for FY 2025-26. The company did not engage this rating provider.
V-Mart Retail Capacity Expansion
V-Mart Retail announced the inauguration of its 600th store, marking a significant milestone. The company added 100 stores over the last year to expand its footprint.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date